Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01229358 · ClinicalTrials.gov registry record · Phase 4
Clinical Trial of a Silver Eluting Dressing System
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 500
- Enrollment target
NCT01229358 is a Phase 4 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 500 participants.
The verdict
NCT01229358, a Phase 4 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 500 participants
- Enrollment target
Study Summary
This prospective, multi-institutional randomized clinical trial of a silver ion eluting dressing material compared to standard dry gauze for closed skin incisions after open surgical revascularizations for peripheral vascular occlusive disease. Based on the ability of the silver to lower the bacterial contamination of these vulnerable surgical skin incisions, the investigators hypothesize that immediate application of Acticoat Absorbent® as a post-operative dressing will reduce closed incisional wound complications in patients undergoing lower extremity revascularizations involving infrainguinal skin incisions compared to standard non-silver eluting dressing material.
Interventions
- OTHER Surgical dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2010-10 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01229358
The ClinicalTrials.gov registry entry for NCT01229358 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Surgical dressing is the first listed.
NCT01229358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01229358 about?
NCT01229358 is a clinical study titled "Clinical Trial of a Silver Eluting Dressing System". This prospective, multi-institutional randomized clinical trial of a silver ion eluting dressing material compared to standard dry gauze for closed skin incisions after open surgical revascularizations for peripheral vascular occlusive disease. Based on the ability of the silver to lower the bacteri...
What is the current status of trial NCT01229358?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 500 participants. The study started on 2010-10. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01229358?
The interventions under investigation include: Surgical dressing (OTHER).
Who is sponsoring clinical trial NCT01229358?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.